Clinical Trial Update: Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluated montelukast for preventing progression in dengue patients with warning signs, with the study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue
• Dengue Shock Syndrome
• Dengue with Warning Signs

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Phramongkutklao College of Medicine and Hospital | Conditions: Dengue, Dengue With Warning Signs | Phase 2, Phase 3 | Status: COMPLETED